ACR Convergence 2020 Archives - Page 30 of 139

Abstract Number: 0312

Dactylitis Is Associated with Greater Disease Severity, Ultrasound Synovitis, and Erosive Damage, in Very Early DMARD Naïve Psoriatic Arthritis
Abstract Number: 1890

Daily Management of Patients with Axial Spondyloarthritis: Self-monitoring of Disease Activity with a Smartphone App Is Feasible – a Proof of Concept Study
Abstract Number: 1061

Daily Myositis Symptom Changes Collected via a Smartphone-Based App Are Associated with Flare Occurrence – Providing Evidence of Potential Digital Biomarkers
Abstract Number: 2036

Damage Trajectories in Systemic Sclerosis Using Group-Based Trajectory Modeling
Abstract Number: 0918

Decline in Forced Vital Capacity in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) with and Without Gastroesophageal Reflux Disease: Further Analyses of the SENSCIS Trial
Abstract Number: 1022

Declining In-hospital Mortality Gap in Lupus Compared to Non-lupus Hospitalizations: A National Study
Abstract Number: 1423

Declining In-Hospital Mortality in Vasculitis: A 17-year U.S. National Study
Abstract Number: 0966

Decoupling Inflammation and Bone Loss in Rheumatoid Arthritis via Schnurri-3
Abstract Number: 1961

Decreased Visits in RISE Practices Due to the SARS-CoV-2 Global Pandemic
Abstract Number: 0423

Defining Ear Chondritis: Data from 685 Patients with Relapsing Polychondritis
Abstract Number: 0391

Defining the Optimal Disease Duration of Early Diffuse Systemic Sclerosis for Clinical Trial Design
Abstract Number: 1939

Definitions and Reliability Assessment of Chronic Ultrasound Lesions of the Axillary Artery in Giant Cell Arteritis: A Study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group
Abstract Number: 0308

Delay in Transition from Psoriasis to Psoriatic Arthritis: A Population Based Study
Abstract Number: 1847

Delayed and Immediate Release Prednisone Decrease Fatigue Comparably in Patients with Systemic Lupus Erythematosus
Abstract Number: 0837

Deletion of miR-223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Faslpr/lpr Mice
Abstract Number: 0848

Delineation of a Proinflammatory Cytokine Profile Targeted by Janus Kinase 1/2 Inhibition Using Baricitinib in a Phase 2 Systemic Lupus Erythematosus Trial
Abstract Number: 1977

Delivering Fracture Prevention Through Telemedicine: A Process Evaluation
Abstract Number: 0050

Demographic Disparities in the Medically Underserved Populations of Southern California: A Rheumatology Cohort of Cytokine Release Syndrome Patients Due to COVID-19
Abstract Number: 0691

Denosumab Did Not Improve Computerized Tomography Erosion Scores When Added to Intensive Urate-Lowering Therapy in Gout: Results from a Pilot Study
Abstract Number: 1442

Denosumab versus Oral Bisphosphonate for Osteoporosis in Long-term Glucocorticoid Users: A 12-month Randomized Controlled Trial
Abstract Number: 0174

Dense Genotyping of Immunologic Loci Identifies CXCR4 as a Novel Susceptibility Locus for Systemic Juvenile Idiopathic Arthritis
Abstract Number: 1291

Depressed Symptomatology Persists over Time in the Majority of Systemic Lupus Erythematosus Patients and Is Independent of Disease Activity
Abstract Number: 0194

Depression Symptoms but Not Clinically Diagnosed Depression Predict Mortality in Rheumatoid Arthritis
Abstract Number: 1062

Dermatomyositis: A Dermatology-Rheumatology Clinic Retrospective Analysis
Abstract Number: 0112

Description of Risk Factors at Baseline and Need of Bone Agent According to Hadji Recommendations in Patients Taking Aromatase Inhibitors as Breast Cancer Therapy
Abstract Number: 1056

Descriptive Data Analysis of Patients with Anti Jo1 Syndrome (AJS) and Lung Involvement
Abstract Number: 1307

Detecting Subtle Changes in Fundoscopic Retinal Images in Patients with Axial Spondyloarthritis with Deep Learning
Abstract Number: 0919

Determinants of Health-related Quality of Life in Systemic Sclerosis
Abstract Number: 1740

Determinants of Influenza Vaccine Hesitancy in Rheumatoid Arthritis According to the WHO-SAGE Matrix
Abstract Number: 0048

Determinants of Participation in Clinical Trials Among Patients with Lupus in the United States
Abstract Number: 1902

Determinants of Physician Global Assessment and Influence of Contextual Factors in Early Axial Spondyloarthritis
Abstract Number: 1986

Determinants of Variation in Pediatric Systemic Lupus Erythematosus Care Delivery
Abstract Number: 0524

Determination of Homogenous Subgroups of Antiphospholipid Syndrome: A Cluster Analysis Based on 509 Cases
Abstract Number: 0189

Determining the Relationship Between Mycobacterium Avium Subspecies Paratuberculosis Serostatus, Dietary Habits, Medication Regimen, and Joint Pain in Patients with Rheumatoid Arthritis
Abstract Number: 1622

Determining the Zoster Vaccination Rate Among Veterans on Chronic Immunosuppressive Therapy at the Southeast Louisiana Veterans Healthcare System – a Quality Indicator
Abstract Number: 1679

Developing a Standardized Corticosteroid Dosing Regimen in Pediatric Proliferative Lupus Nephritis
Abstract Number: 0549

Developing an Algorithm for Identifying Mortality in MarketScan Claims Data Using Machine Learning
Abstract Number: 1707

Development and Delivery of Continuing Education Interventions Promoting Shared Decision Making in Rheumatoid Arthritis
Abstract Number: 0322

Development and Preliminary Validation of Smartphone Sensor-based Measurement Tools for Psoriatic Arthritis
Abstract Number: 2018

Development and Validation of an Artificial Intelligence Approach for the Detection of Radiographic Sacroiliitis
Abstract Number: 1701

Development and Validity Evidence for a Tool to Assess the Performance of Shoulder Injections
Abstract Number: 1879

Development of a Deep Learning Algorithm to Predict Positive MRI of the Sacroiliac Joints According to the ASAS Definition in Patients with Recent Axial Spondyloarthritis
Abstract Number: 1147

Development of a Digital Toolkit to Improve Quality of Life of Patients with Systemic Lupus Erythematosus: A Pilot Study
Abstract Number: 1731

Development of a Disease Activity Index for Rheumatoid Arthritis Patients Using the HandScan
Abstract Number: 0961

Development of a Pain Sensitivity Index to Examine the Transition from Intermittent to Constant Pain in Knee Osteoarthritis: The Multicenter Osteoarthritis Study
Abstract Number: 0796

Development of a Tool to Assess Synovial Tissue Infiltrates and Derive Histological Pathotype in Inflammatory Arthritis: Relationship to Clinical and Ultrasound Variables
Abstract Number: 0117

Development of an In Vitro Trabecular Human Bone Model to Recapitulate Features of Glucocorticoid-induced Osteoporosis
Abstract Number: 1667

Development of Autoimmune Diseases and HLA Associations in Children with Neonatal Lupus and Their Unaffected Siblings
Abstract Number: 1870

Development of Candidate Criteria for Axial Disease in Juvenile Spondyloarthritis: An International Collaboration
Abstract Number: 0745

Development of Functional Assays to Pre-qualify Human Mesenchymal Stem Cells for Rheumatoid Arthritis Treatment
Abstract Number: 0522

Development of New International Classification Criteria for Antiphospholipid Syndrome: Phase III Case Collection Results
Abstract Number: 1877

Diagnosis of Axial Spondyloarthritis: A Primary Unmet Educational Need for Rheumatologists Is Interpretation of MRI
Abstract Number: 0092

Diagnosis of Behçet’s Disease: Comparison of Two Sets of Classification Criteria. Application in 111 Patients of a Well-defined Population
Abstract Number: 0309

Diagnostic Delay in Psoriatic Arthritis: A Population Based Study
Abstract Number: 1075

Diagnostic Utility of Myositis Antibodies in HyperCKemia: A University Affiliated Single Center Retrospective Study
Abstract Number: 1539

Diagnostic Value of Ultrasound Halo Count and Halo Score in Giant Cell Arteritis: A Retrospective Study from Routine Care
Abstract Number: 0734

Differences and Similarities Between down Syndrome-associated Arthritis and Juvenile Idiopathic Arthritis in the New Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
Abstract Number: 1874

Differences Between Men and Women in the Patient Pathways to Diagnosis of Ankylosing Spondylitis
Abstract Number: 0612

Differences in 30-Day Rehospitalization Risk and Predictors by Age Group Among Patients with Lupus in Medicare
Abstract Number: 1787

Differences in Chromatin Architecture Between Treatment Naïve Pediatric and Adult Lupus Patients
Abstract Number: 0486

Differences in Low-density Lipoprotein (LDL) Particle Composition and Oxidation May Underlie the Paradoxical Association of Low LDL with Higher Coronary Atherosclerosis Burden in Rheumatoid Arthritis
Abstract Number: 0708

Differences in Treating Knee Osteoarthritis by Clinician Specialty
Abstract Number: 1851

Different Disease Activity Trajectories in Early Axial Spondyloarthritis Lead to Significantly Different Long-term Outcomes : A Cluster-based Analysis of the DESIR Cohort
Abstract Number: 0417

Different Immunophenotypes Characterized IgG4-Related Disease Clinical Phenotypes
Abstract Number: 0016

Differential Characteristics in Inflammatory Rheumatologic Patients with Severe and Mild COVID-19 Infection
Abstract Number: 1403

Differential Effect of Abatacept vs TNF Blockers, on the Frequency of Circulating Follicular Helper (Tfh) and Periperal Helper (Tph) T Cells in Rheumatoid Arthritis
Abstract Number: 1399

Differential Impacts of TNFa Inhibitors on the Expression of Th Cytokines
Abstract Number: 0482

Differential Influence of CDAI Components Based on Disease State in Rheumatoid Arthritis Patients: Real World Results from a Rheumatoid Arthritis Cohort
Abstract Number: 0998

Differential Roles of TNFRI and TNFRII in the Morphology of Secondary Lymphoid Organs
Abstract Number: 1529

Differentially Expressed Chemokines and Cytokines in Peripheral Blood Mononuclear Cells (PBMCs) of Rheumatoid Arthritis (RA) Patients
Abstract Number: 0082

Diffuse Sclerosing Osteomyelitis of the Jaw: An Underdiagnosed Disease in Maxillofacial Surgery Department
Abstract Number: 1396

Digital Artery Volume Index (Davix©) Predicts Onset of Future Digital Ulcers in Patients with Systemic Sclerosis
Abstract Number: 1380

Digital Occlusive Arterial Disease on Laser Doppler Flowmetry Increases the Risk of Digital Ischemic Complications in Systemic Sclerosis: Results from a Single Center Referral Cohort (2001-2018)
Abstract Number: 0830

Discontinuation Rate of Tofacitinib Is Similar When Compared to TNF Inhibitors in Rheumatoid Arthritis Patients: Real World Results from a Rheumatoid Arthritis Cohort
Abstract Number: 1129

Discordance in Patient and Physician Assessment of Disease Activity in Relapsing Polychondritis
Abstract Number: 1213

Discrepancy Between the Multi-biomarker Disease Activity Score and Clinical Disease Activity Scores in a 2‑Part, Multicenter Study of Repository Corticotropin Injection (Acthar® Gel) for Patients with Persistently Active Rheumatoid Arthritis
Abstract Number: 0611

Disease Activity and Disability Are Not Associated with Rehabilitation Utilization in African Americans with Rheumatoid Arthritis
Abstract Number: 1295

Disease Activity and Mental Health in SLE Patients: A Cross-section Study with Self-Assessments Based on Smart System of Disease Management (SSDM) Mobile Tools
Abstract Number: 1319

Disease Activity and Mental Health of as Patients: A Cross-section Study with Self-assessments Based on Smart System of Disease Management (SSDM) Mobile Tools
Abstract Number: 0405

Disease Activity and Quality-of-Life Outcomes in Patients with Behçet’s Syndrome Who Achieved and Maintained Oral Ulcer Complete Response with Apremilast Treatment
Abstract Number: 1884

Disease Activity in an Axial Spondyloarthritis Cohort During the COVID-19 Pandemic
Abstract Number: 1714

Disease Activity Trajectories for Early and Established Rheumatoid Arthritis: Real World Results from a Rheumatoid Arthritis Cohort
Abstract Number: 0674

Disease Control of Hyperuricemia Newly Detected by Medical Check-up: A Retrospective Cohort Study of Health Insurance Claims Data in Japan
Abstract Number: 2041

Disease Features of Systemic Sclerosis Are Associated with Alterations in Gastrointestinal Microbial Composition in Two Independent Cohorts
Abstract Number: 1764

Disease Modifying Anti-rheumatic Drug and Biologic Therapy in Pregnancy: A Single-center Mixed Methods Study
Abstract Number: 1014

Disease Modifying Anti-rheumatic Drugs, Biologics and Corticosteroid Use in Older Patients with Rheumatoid Arthritis over 20 Years
Abstract Number: 1401

Disease Mutation That Weakens ZAP70 Autoinhibition Enhances Responses to Weak and Self Ligands
Abstract Number: 0448

Disease-related factors associated to atherosclerotic disease in axial spondyloarthritis. A mutlicenter study with 806 patients.
Abstract Number: 0442

Disparities in CoronaViridae Infection Are Readily Apparent in Rheumatology Patients Despite Use of Hydroxychloquine And/or Methotrexate
Abstract Number: 0049

Disparities in Patient Portal Use Among Patients with Rheumatic and Musculoskeletal Diseases in a Large Academic Medical Center
Abstract Number: 0035

Distinct Biological Pathways in Both Blood and Kidney Further Define Molecular Profiles Across Diverse Nephritides
Abstract Number: 0030

Distinct DNA Methylation Patterns of Rheumatoid Arthritis Peripheral Blood and Synovial Tissue T Cells
Abstract Number: 1154

Distinct Gene Signature Predicts Strong Clinical Responses to Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis
Abstract Number: 0702

Distinct Murine Cartilage Microbial DNA Signatures Are Seen in High Fat Diet-Induced Obesity and Aging
Abstract Number: 1493

Distinct Patient-level Patterns of Response to Methotrexate in Juvenile Idiopathic Arthritis
Abstract Number: 1571

Distinct T Cell Responses in Inflammatory Arthritis Associated with Combined CTLA-4 and PD-1 Inhibitor Therapy
Abstract Number: 1811

Distinctive Molecular Signatures Among Monocytes from Childhood- and Adult-onset Systemic Lupus Erythematosus: Clinical Involvement and Relevance of Sustained Anti-dsDNA Positivity
Abstract Number: L05

DMARD Changes for Patients with Rheumatoid Arthritis in the US During the First Three Months of the COVID-19 Pandemic
Abstract Number: 1907

DNASE1L3 R206C Polymorphism, a Systemic Sclerosis Risk Factor, Causes Impaired Digestion of Genomic DNA in Apoptosis-derived Extracellular Vesicles
Abstract Number: 1657

Do Comorbidities Limit Improvement in Pain and Physical Function After Total Knee Arthroplasty in Patients with Knee Osteoarthritis?
Abstract Number: 0620

Do Physical Therapists Follow Evidence-Based Practice Recommendations for Treatment of Inflammatory Arthritides?
Abstract Number: 1662

Do Weight-bearing versus Non-weight-bearing Pain Reflect Different Pain Mechanisms in Knee Osteoarthritis?: The Multicenter Osteoarthritis Study
Abstract Number: 1611

Documentation of Pregnancy Counseling in SSA-Positive Patients of Childbearing Potential: A Cross-Sectional Study
Abstract Number: 1278

Does Co-existing Systemic Lupus Erythematosus Affect Outcomes of Hospitalizations for Ischemic Stroke?
Abstract Number: 0260

Does Higher Quality of Care in SLE Improve Quality of Life?
Abstract Number: 1334

Does Interstitial Lung Disease Represent a Real Comorbidity in Spondyloarthritis Patients? Results from an Ultrasound, Monocentric, Pilot Study
Abstract Number: 1741

Does Preventive Care Matter? (in RA)
Abstract Number: 0358

Does Smoking Affect Secukinumab Treatment Outcomes and Safety in Patients with Ankylosing Spondylitis? – Real World Data from German Observational Study
Abstract Number: 0360

Does Smoking Affect Secukinumab Treatment Outcomes and Safety in Patients with Psoriatic Arthritis? – Real World Data from German Observational Study
Abstract Number: 0097

Does Testing for SAA Is More Beneficial Than CRP for the Follow-up of Patients with FMF?
Abstract Number: 0769

Does the Autoantibody-Response Mature Between Presentation with Arthralgia and Development of Rheumatoid Arthritis? – a Longitudinal Serological Study
Abstract Number: 0014

Does the Type of Rheumatic Disease or Biologic Treatment Increase the Risk of Developing Severe COVID-19?
Abstract Number: 0994

Does Tofacitinib Impact B Cell Functions?
Abstract Number: 0110

Does Urate Directly Influence Bone Turnover? Randomized Controlled Trial of Inosine Supplementation
Abstract Number: 1538

Doppler Ultrasound Predicts Successful Discontinuation of Biological DMARDs in Rheumatoid Arthritis Patients in Sustained Clinical Remission
Abstract Number: 0466

Dosage Modification of Immunomodulatory Medications by Rheumatology Patients in New York City During the Peak of the COVID-19 Pandemic
Abstract Number: 0058

Drug Retention and Discontinuation of Biological DMARDs and Novel Small Molecules: Data from the Singapore National Biologics Registry
Abstract Number: 0917

Drug-Drug Interaction Study of Nintedanib (Ofev®) and the Combination of Ethinylestradiol and Levonorgestrel (Microgynon®) in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
Abstract Number: 0648

Dual Energy CT Has Additional Prognostic Value over Clinical Measures in Gout Including Tophi: Best Evidence Synthesis
Abstract Number: 0445

Dual-Energy CT in Gout Patients: Do All Color-Coded Lesions Actually Represent Monosodium Urate Crystals?
Abstract Number: 0954

Dual-energy CT Predicts Mortality in Gout Patients: A 3-year Follow-up Cohort Study
Abstract Number: 0647

Dual-energy CT versus Ultrasound, Alone or in Combination, for the Diagnosis of Gout: A Diagnostic Performance Study
Abstract Number: 1815

Dynamic Changes in Microbiota Representation of a Gut Pathobiont and Clinical Disease Activity in Patients with Lupus Nephritis
Abstract Number: 0251

Dynamics of Anti-Nuclear Antibodies in a Longitudinal Study of a Large Systemic Lupus Erythematosus Cohort
Abstract Number: 0768

Dynamics of Follicular Helper T Cells Subsets in Rheumatoid Arthritis Patients Before and After Treatment
Abstract Number: 1956

Dysregulated Expression of the Long Non-coding RNA, LINC01871, Implicated in Sjögren’s Syndrome Pathogenesis